Updated This Week
Vital Research Daily
Diabetes Desk
Diabetes • Special Report

What Your A1C Hides From You — And Why Your Urine Reveals It First

A Harvard-led research team has identified a layer of toxic residue coating the pancreas of nearly every type 2 diabetic — and a simple morning blend appears to dissolve it.

Watch the investigation

The protocol uses three ingredients you likely already have in your kitchen — combined in a specific ratio first published in the Harvard team's findings.

If you're living with type 2 diabetes — or watching your A1C creep up despite doing everything your doctor told you — there's a fact most physicians won't share with you. Your A1C test does not show the actual cause of your condition. It only measures the symptom.

The real cause, according to a research team at Harvard Medical School, has been hiding in plain sight for forty years. And once you understand it, almost everything you've been told about managing diabetes starts to feel different.

Show Me What My A1C Hides →

Free presentation • No email required • Watch directly

Does this sound like you?

You've done everything right. The numbers still don't move.

You've taken the metformin. You've cut the carbs. You've pricked your finger every morning and rearranged your entire life around those numbers.

And after all of it — your glucose still spikes. Your energy still collapses by 2 PM. Your doctor still says, "we might need to adjust the dose."

It doesn't add up — unless something else is going on. Something the standard A1C test was never designed to detect.

Published research

Harvard. Mayo Clinic. Newcastle. The research is pointing in the same direction.

For over a decade, teams at Harvard Medical School, the Mayo Clinic, and Newcastle University have been documenting a quiet shift in how type 2 diabetes is understood. The picture they're building doesn't match the one most patients have been given.

The most striking confirmation came in 2018. A randomized clinical trial called DiRECT, published in The Lancet, followed 298 adults with type 2 diabetes through a structured 12-month intervention. 46% achieved remission. Among those who lost 15kg or more, 86% achieved remission. The control group: zero.

Behind the trial was a hypothesis that had been forming across these institutions for years — that fat accumulation in the liver and pancreas was the upstream driver of type 2 diabetes, and that insulin resistance was a downstream consequence, not the starting point.

From the published research

"Type 2 diabetes is a reversible condition of intra-organ fat excess to which some people are more susceptible than others."

— Prof. Roy Taylor, Newcastle University. Banting Memorial Lecture; corresponding work in The Lancet (2018) and Journal of Internal Medicine (2021). View original research →

The 2018 trial confirmed what the broader research had been pointing to. The 2021 follow-up extended the findings. The NHS now operates a national remission program based on this body of work — and the implications are still working their way into U.S. clinical practice.

For families watching loved ones manage the condition year after year, this isn't fringe theory. It's peer-reviewed, replicated across multiple institutions, and increasingly recognized.

See How the Research Translates →

Full briefing — free to watch

What changes on the other side

Imagine the morning your numbers finally make sense.

We can't tell you here exactly what shifts. The interview lays out the reasoning piece by piece, and we don't want to flatten it into a paragraph that wouldn't do it justice. But we can tell you what people describe — almost word for word — when something they didn't expect starts working.

"It wasn't dramatic. It wasn't sudden. It just… started working." — from a reader letter, this week

None of that is promised, and results vary — they always will. What's striking, and what convinced us to publish this, is how consistent the language is across the messages we've received. People aren't describing a slow improvement. They're describing surprise.

Reader letters this week

A few of the messages we've received since covering this.

"First time in eleven years, my morning numbers came in where they should be. My wife cried. I cried. My doctor is the one asking what I did."

Michael R.
Michael R. — Ohio
Verified user

"The 2 PM crash is gone. My feet feel like my feet again. I've been showing the printouts to my whole family — they don't believe what they're seeing."

Diane W.
Diane W. — Texas
Verified user

"I was weeks away from a serious change in my routine. The blood work last month told a completely different story. My doctor said: whatever you're doing, keep doing it."

Linda S.
Linda S. — Florida
Verified user
Editor's note

We are not the publisher of the original presentation. We're linking to it because we believe the content is worth viewing. The presentation is currently free to view in full; if you have time set aside, it's worth watching from beginning to end in one sitting.

Watch the Full Briefing →

Approximately 45 minutes · Free to view

Medical disclaimer: This page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

Individual results vary. Testimonials reflect the experience of specific users and are not a guarantee that you will achieve the same results. Always consult a qualified physician before starting any new supplement, especially if you are managing type 2 diabetes, taking prescription medication, pregnant, or under 18 years of age. Do not discontinue any prescribed medication without medical supervision.

References to "Ozempic," "Mounjaro," "Jardiance," and other branded medications are made for comparison and educational purposes only. This product is not affiliated with, endorsed by, or sponsored by the manufacturers of those medications.

Watch the Full Briefing →